Abstract
Implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy (CRT) are, consecutively, the primary and secondary prevention strategies to accomplish sufficient dysrhythmias management. We aim to investigate the influence of chronic kidney disease (CKD) on cardiovascular outcomes and inpatient mortality in patients who are hospitalized for ICD or CRT implantations.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
